AHFS February 2025 Update

This update contains 6 new monographs and 21 revised monographs.

New monographs: Acoramidis Hydrochloride; Eladocagene Exuparvovec-tneq; Obecabtagene Autoleucel; Revumenib Citrate; Sulopenem etzadroxil and probenecid; Zanidatamab-hrii.

Revised monographs: Alpelisib; Aprocitentan; Aztreonam; Copyright and Notices; Empagliflozin; Ensifentrine; Epcoritamab-bysp; Furosemide; Iptacopan Hydrochloride; Ivacaftor; Ketamine Hydrochloride; Losartan Potassium; Obeticholic Acid; Omalizumab; Osimertinib Mesylate; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine, Adjuvanted; Risankizumab-rzaa; Ustekinumab; Vericiguat.